Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed

Oncotarget. 2017 Dec 15;8(66):110732. doi: 10.18632/oncotarget.23291.

Nasha Zhang^{1

2}, Li Kong^{2

3}, Fang Shi^{2

3}, Wang Jing², Haiyong Wang^{2

3}, Ming Yang^{2

3}, Jinming Yu^{2

3}, Hui Zhu^{2

3}

¹ Cheeloo College of Medicine, Shandong University, Jinan, China.
² Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China.
³ Shandong Academy of Medical Sciences, Jinan, China.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.20456.].